1,4-androstadiene-3,17-dione has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barmade, MA; Murumkar, PR; Tamboli, RS; Yadav, MR | 1 |
| El-Halawany, AM; Gamal-Eldeen, AM; Hegazy, ME; Mohamed, Ael-H; Paré, PW | 1 |
| Covey, DF; Hood, WF | 1 |
1 review(s) available for 1,4-androstadiene-3,17-dione and Breast Cancer
| Article | Year |
|---|---|
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Female; Humans; Models, Molecular; Molecular Structure | 2015 |
2 other study(ies) available for 1,4-androstadiene-3,17-dione and Breast Cancer
| Article | Year |
|---|---|
Steroidal metabolites transformed by Marchantia polymorpha cultures block breast cancer estrogen biosynthesis.
Topics: Androstadienes; Apoptosis; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Catalytic Domain; Cell Line, Tumor; Computer Simulation; Estrogens; Female; Humans; Kinetics; Marchantia | 2012 |
A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Topics: Androstadienes; Androstatrienes; Androstenedione; Androstenes; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy; Structure-Activity Relationship; Testolactone | 1982 |